Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Telix Pharmaceuticals
Biotech
Cell-focused Sana scoops first CSO—Chutes & Ladders
Sana Biotechnology plucks new CSO. Eliem adds new COO. Telix shakes up C-suite.
Darren Incorvaia
,
Zoey Becker
,
Gabrielle Masson
Aug 30, 2024 8:30am
Radiopharma biotech Telix drops Nasdaq IPO plans at last minute
Jun 14, 2024 5:37am
Radiopharma-focused Telix targets $200M IPO
Jun 5, 2024 10:57am
Telix offers $33M to acquire Qsam and phase 1 bone cancer drug
Nov 14, 2023 8:20am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
Abzena licenses PSMA antibodies to Telix
Jul 18, 2017 8:46am